Stefania Capone is a highly motivated and experienced scientist who spent most of her career in biotech and pharmaceutical industry, with a key role in the preclinical and early clinical development of new candidate vaccines based on viral vector platforms. Trained in immunology, with emphasis on the study of T cell responses in animal models and in humans.